IFF International Flavors & Fragrances, Inc. Common Stock
O International Flavors & Fragrances, Inc. Common Stock Przegląd firmy z Wikipedii
International Flavors & Fragrances Inc. (IFF) is an American corporation that creates products across taste, texture, scent, nutrition, enzymes, cultures, soy proteins, and probiotics categories, which it markets globally. It is headquartered in New York City and has creative, sales, and manufacturing facilities in 44 countries. The company is a member of the S&P 500 index.
Czytaj więcej
International Flavors & Fragrances Inc. (IFF) is an American corporation that creates products across taste, texture, scent, nutrition, enzymes, cultures, soy proteins, and probiotics categories, which it markets globally. It is headquartered in New York City and has creative, sales, and manufacturing facilities in 44 countries. The company is a member of the S&P 500 index.
History
International Flavors & Fragrances was formed in 1958 by the merger between Polak & Schwarz (P&S) and van Ameringen-Haebler.
Origins
Polak & Schwarz was founded in 1889 by Leopold Schwarz, who had an interest in spices, flavors, and fragrances, and his brother-in-law, Joseph Polak in the small Dutch town of Zutphen. P&S quickly grew to 36 sites globally. Arnold Louis (A.L.) van Ameringen was hired by Polak & Schwarz to open P&S's U.S. office in 1917 before losing his job with them. Relieved of his duties, he opened van Ameringen & Co. at 13 Gold Street in Manhattan, took over Morana, Inc. in 1920, and became van Ameringen-Haebler (VAH) in 1929.
Constant Cornelis (Cook) Brummer was a director at Polak & Schwarz during World War II. Because he saved hundreds of Jewish workers' lives, he is compared to Oskar Schindler. He was recognized by Israel as Righteous Among the Nations in January 2017, for risking his own life to save others from the Nazis.
Merger and early growth
The two companies did well through the bulk of the 20th century, despite difficulties for P&S during World War II. While both companies managed flavors and fragrances, Polak & Schwarz had particular strengths in flavors and van Ameringen-Haebler built a powerful reputation in fragrances. In 1958, the two companies announced their merger to become International Flavors & Fragrances Inc. IFF was listed on the New York Stock Exchange in 1964. It was cross listed to the Euronext Paris Market in 2015, becoming the first U.S.-listed company to make use of Euronext Paris Fast Path process.
Research and innovation
In 1968, in conjunction with the Monell Foundation, IFF established the Monell Chemical Senses Center, dedicated to the research of taste and smell.
In 1985, Dr. Braja D. Mookherjee, a scientist at IFF, pioneered Living Flower technology, which changed the way perfumes are created. The technology allows for the most accurate transmission of the scent of real flowers through perfume ingredients. In 1990, IFF broke ground in their R&D facility located in Union Beach, NJ, to develop its 5,000-square-foot greenhouse and botanical garden, which can maintain tropical and subtropical temperature zones for more than 1,300 varieties of exotic plants.
It is home to a miniature rose called "Overnight Scentsation" (also known as the "Space Rose") which was cultivated for experiments in space and left the Earth during a 10-day flight on board the shuttle Discovery (STS-95) in 1998. Low gravity critically altered the fragrance of the rose, which was later commercialized by IFF and Shiseido.
Leadership
Henry G. Walter, Jr., former IFF Chairman, 1962–1985, was a noted philanthropist and prolific writer, who pioneered the field of aromatherapy. He is considered one of the most influential people in the Industry. It has been speculated that he inspired some of the storylines and characters in the book Masters of Sex by Thomas Maier, as well as the Showtime series by the same the name. During World War II, his wife, Rosalind (Palmer) Walter worked on the night shift as a riveter on the Corsair, the F4U Marine gull-winged, fighter airplane, inspiring the song "Rosie the Riveter."
Acquisitions and divestitures (2000–2016)
In 2000, IFF acquired Laboratoire Monique Rémy based in Grasse, France and forms IFF LMR Naturals, strengthening its position in the development and use of raw materials, natural ingredients for fragrances and flavors. In 2000, IFF acquired Bush Boake Allen with its complementary products, technologies, and presence in key markets, making IFF the largest flavor and fragrance house in the world for several years.
In 2014, IFF acquired Aromor Flavors and Fragrances Ltd., a privately held manufacturer and marketer of complex specialty ingredients that are used in fragrances and flavors based in Israel in Kibbutz Givat Oz.
In 2015, IFF announced that it completed the acquisition of Ottens Flavors. This was followed in 2016 with the acquisition of David Michael & Company. Using this merger as a catalyst, they have since launched Tastepoint by IFF to serve dynamic middle-tier customers.
In 2015, IFF acquired Lucas Meyer Cosmetics, a cosmetic actives firm based in Canada that develops, manufactures and markets innovative ingredients for the cosmetic and personal care industry. Lucas Meyer Cosmetics was sold to Clariant in April 2024.
Corporate profile
IFF has creative, sales, and manufacturing facilities in 44 countries and is a member of the S&P 500 Index. IFF is a $10.8 billion market capital company with a global footprint that generated over 75 percent of its 2016 sales outside the United States and 51 percent in the emerging markets. In 2014, the Company celebrated its 125th anniversary year, from the founding of Polak & Schwarz on January 27, 1889 in Zutphen, Netherlands, to the 1958 merger with van Ameringen-Haebler to form IFF. IFF is ranked among Forbes Best Employers.
Frutarom acquisition and shareholders
On May 8, 2018, IFF acquired the Israeli company Frutarom for $7.1 Billion.
Between 2016 and 2018, Kirsten, Finn and Jorn Rausing became the top shareholders of IFF, having bought nearly 20% of the shares via entities in Singapore and Liechtenstein.
Recent transactions (2019–present)
In 2019, IFF announced the merger of IFF and DuPont's Nutrition & Biosciences (N&B) business in a Reverse Morris Trust transaction. The deal values the combined company at $45.4 billion on an enterprise value basis, reflecting a value of $26.2 billion for the N&B business based on IFF's share price as of December 13, 2019.
In December 2022, French private equity firm PAI Partners announced their acquisition of IFF's Savory Solutions Group, which is valued at about $900 million. Upon the deal's completion, the private equity firm rebranded the solutions group as NovaTaste.
In March 2024, it was announced IFF has sold its IFF Pharma Solutions division to the France-based family owned company, Roquette for $2.85 billion.
CEOs
Jon Erik Fyrwald: 2024–present
Frank Clyburn: 2022–2024
Andreas Fibig: 2014–2022
Doug Tough: 2010–2014
Robert Amen: 2006–2009
Fragrances
IFF created many well-known fragrances, including:
Prince Matchabelli's Wind Song (1952), perfumers Ernest Shiftan and Léon Hardy
Estée Lauder's Youth-Dew (1953), perfumer Joséphine Catapano
Estée Lauder's Aramis (1963), perfumer Bernard Chant
Estée Lauder's Estée (1968), perfumer Bethy Bussé
Norman Norell's Norell (1968), perfumer Joséphine Catapano
Clinique's Aromatics Elixer (1971), perfumer Bernard Chant
Estée Lauder's Aliage (1972), perfumer Francis Camail
Jōvan's Jōvan Cologne (but not Jōvan Musk) (1972), perfumer Murray Moscona
Estée Lauder's Private Collection (1973), perfumer Vincent Marcello
Halston's Halston (1975), perfumers Bernard Chant and Max Gavarry
Halston's Z-14 (1976), perfumers Vincent Marcello and Bernard Chant
Ralph Lauren's Polo (1978), perfumer Carlos Benaïm
Ralph Lauren's Lauren (1978), perfumer Bernard Chant
Estée Lauder's White Linen (1978), perfumers Ernest Shiftan and Sophia Grojsman
Antonia Bellanca's Antonia's Flowers's (1984), perfumers Bernard Chant and Joséphine Catapano
Estée Lauder's Beautiful (1985), perfumers Bernard Chant, Carlos Benaïm, Nicholas Calderone, Max Gavarry, and Sophia Grojsman
Estée Lauder/Prescriptives's Calyx (1986), perfumer Sophia Grojsman
Calvin Klein's Eternity (1988), perfumer Sophia Grojsman
Elizabeth Arden's Red Door (1989), perfumers Carlos Benaïm and Olivier Gillotin
Elizabeth Taylor's White Diamonds (1991), perfumers Carlos Benaïm and Olivier Gillotin
Donna Karan's Cashmere Mist (1994), perfumer Nicholas Calderone
Clinique's Happy (1997), perfumers Rodrigo Flores-Roux and Jean-Claude Delville
Fragrance ingredients
Amber scents
Amber Xtreme
Ambermor
Ambermor Ketal Crystal
Ambermor Ketal IPM
Ambermor-Ex
Ambrinol 95
Bornafix
Cashmeran
Cashmeran Velvet
Cetalor
Grisalva
Operanide
Trisamber
Citrus scents
Bergamal
Citral Dimethyl Acetal
Citrolate
Clonal
Dimyrcetol
Dipentene 5100
Herbalime
Hypo-LEM
Limoxal
Myrcenol Super
Myrcenyl Acetate
Nootkatone Crystals
Nootkatone Natural Crystals
Octacetal
Orange Flower Ether
Pamplefleur
Terpinolene 20
Terpinolene 90
Terpinolene 90 PQ
Terpinolene Rectified
Tetrahydro Myrcenol
Valencene
Verbenal
Floral scents
Anisimea
Aquaflora
Auralva
Citronellol 700
Citronellol 950
Citronellyl Propionate
Cyclemax
Damascenone 93% Min.
Damascenone 98% Min.
Damascol
Dihydro Terpineol
Dimethyl Octanol
Dimethyl Phenyl Ethyl Carbinyl Acetate
Fleuramone
Floral Super
Floralozone
Gelsone
Geraniol 600
Geraniol 7030
Geraniol 950 SG
Geraniol 980 Pure
Geranyl Formate
Geranyl Propionate
Helional
Hyacinth Body
Hyacinth Body No. 3
Hydratropic Aldehyde DMA
Hydroxyol
Indolene 50% BB
Jasmal
Jessemal
Kharismal
Kharismal Super
Lavonax
Lilianth
Lindenol
Lyral
Lyrame Super
Meijiff
Melafleur
Methyl Lavender Ketone
Muguesia
Muguet Ald 50% BB
Nerol 900
Peomosa
Phenafleur
Phenoxanol
Phenyl Acetaldehyde Glycerine Acetal
Phenyl Ethyl Benzoate
Phenyl Ethyl Phenyl Acetate
Pseudo Linalyl Acetate
Reseda Body
Rosalva
Rosethyl
Starfleur
Terpineol 900
Terpineol Alpha JAX
Terpineol AP
Terpineol Extra
Terpinol
Tetrahydro Muguol
Violiff
Ylanganate
Fresh scents
Intreleven Aldehyde
Intreleven Aldehyde Special
Maritima (compound)
Myrac aldehyde
Oceanol
Ozofleur
Pino Acetaldehyde
Precyclemone B
Fruity scents
Beta Naphtyl Isobutyl Ether
Cassiffix
Citronellyl Acetate
Citronellyl Formate
CP Formate Aphermate
Cuminyl Acetate
Cyclabute
Cyclemone A
Damascone Alpha
Damascone Beta
Damascone Delta
Dulcinyl Recrystallized
Ethyl Phenyl Glycidate
Fraistone
Fructone
Geranyl acetate A
Geranyl Acetate Extra
Geranyl Acetate Pure
Geranyl Iso Butyrate
Hexalon
Hexyl acetate
Iso Amyl Butyrate
Nectarate
Neryl Acetate JAX
Prenyl Acetate
Terpinyl Acet Jax
Terpinyl Acetate
Terpinyl Acetate Extra
Tropicalia
Undecalactone Gamma Coeur
Vanoris
Green scents
Galbascone 95
Cortex Aldehyde 50% TEC
Galbascone
Galbascone High Alpha
Hexenyl Salicylate CIS-3 (cis-3-hexenyl salicylate)
Iso Cyclo Citral
Liffarome
Melozone
Montaverdi
Syvertal
Vertoliff
Vivaldie
Herbal scents
Canthoxal
Dihydro Cyclacet
Dihydro Terpinyl Acetate
Fleuranil
Herbac
Ocimene
Ocimenyl Acetate
Oxaspirane-819
Pinane
Salicynalva
Unipine 60
Unipine 85
Verdol
Verdone
Leather scents
Isobutyl Quinoline
Musk scents
Ambrettolide
Celestolide
Edenolide
Galaxolide
Galaxolide 50% BB
Galaxolide 50% DEP
Galaxolide 50% DPG
Galaxolide 50% IPM
Galaxolide Undiluted
Hexadecanolide
Luminide
Muscemor
Musk Z 4
Zenolide
Powdery scents
Bicyclononalactone
Spicy scents
Cinnamalva
Cuminyl Alcohol
Iso Cyclo Geraniol
Prismantol
Veraspice
Woody scents
Andrane
Bacdanol
Cupressus funebris wood oil
Cedrafix
Cedramber
Cedryl Acetate
Coniferan Pure
Hexenyl Benzoate CIS-3
Hexyl benzoate
Iso E Super
Karmawood
Koavone
Kohinool
MCK Chinese
MCK SG
Meth Ionone Alpha Extra
Meth Ionone Beta Coeur
Meth Ionone Gamma A Tocopherol
Meth Ionone Gamma Coeur
Meth Ionone Gamma Pure
Mysantol
Orivone
Piconia
Sanjinol
Santaliff
Timbersilk
Tobacarol
Trimofix
Veramoss
Vertofix Coeur
Environmental record
IFF published its first external sustainability report: Sustainability: The Essence of IFF in 2011. In 2012, IFF adopted the 12 Principles of Green Chemistry as an important differentiator in product design and development.
In 2014, IFF opened a 4,000 kilowatt Photovoltaic Solar Installation in New Jersey, which supplies approximately 40 percent of the electricity needs of its Hazlet, NJ fragrances manufacturing and creative center facilities. It has more than 16,000 modules and approximately 1 million solar cells covering 20 acres of IFF property, making IFF a leader in renewable energy in its sector.
In 2015, IFF achieved LEED Silver Certification for its Flavors Creative Center in Indonesia and achieved Roundtable for Sustainable Palm Oil (RSPO) Supply Chain Certification for its facilities in the United States, the United Kingdom and the Netherlands.
In 2015, Coca-Cola, FUJIFILM, International Flavors and Fragrances, Agristo, Cofely and Water Board De Dommel opened a collective wastewater treatment plant on the premises of FUJIFILM in Tilburg, Netherlands. The wastewater treatment plant can process about 10 million litre per day or more than 3.5 billion litre wastewater per year. The plant has a low level of energy consumption and implements the latest technology in the field of water treatment. After treatment, the wastewater is discharged as clean water into the Wilhelmina Canal, making it available for reuse by the four companies, or for another sustainable use in the Tilburg region.
In 2016, IFF was awarded a place on the CDP Climate "A" List for the 2nd year in a row and achieved a 7% year-over-year reduction in GHG emissions intensity. IFF also became the first flavors and fragrances company to join Together for Sustainability (TfS), driving responsible sourcing throughout their supply chain.
In 2016, IFF deployed the industry's first-ever on-site wind turbine at its Tilburg, Netherlands manufacturing facility. It has an output of 2.4 megawatts, producing approximately 6.5 million kWh of renewable electricity per year, which provides up to 30 percent of the site's electricity needs, and when combined with purchased green electricity the facility is powered by 100 percent renewable electricity.
In 2016, IFF released the First-Ever Cradle to Cradle Certified™ Fragrance: PuraVita™. Designed through a mindset of sustainability the fragrance earned IFF a Platinum level Material Health Certificate.
In 2016, IFF and Unilever launched the Vetiver Together Partnership to Improve the Lives of Vetiver Farming Communities in Haiti and strengthen the supply chain. The project is supported by the Enhancing Livelihoods Fund – a partnership between Unilever, Oxfam Great Britain, and the Ford Foundation and is being implemented by Heifer International in Haiti.
IFF is rated gold by EcoVadis for sustainability, which ranks it as a top supplier and partner.
In 2017, IFF, headquartered in Manhattan, New York City, joined the We Are Still In network demonstrating America's enduring commitment to tackling climate change, ensuring a clean energy future, and upholding the Paris Agreement. IFF announced that it joined the American Business Act on Climate Pledge in 2015.
In 2017, International Flavors & Fragrances' South Brunswick, New Jersey facility earned GreenCircle Certified LLC Zero Waste to Landfill facility status, making it the only facility of its kind in the flavor and fragrance industry to achieve GreenCircle's zero waste status.
IFF was recognized as one of the top green companies in the U.S. in the 2016 Newsweek Green Rankings and named on Barron's 100 Most Sustainable Companies List in 2018.
Partnerships
In 2001, IFF collaborated with the Cosmetic Executive Women (CEW) at the Raymond-Poincaré hospital in Garches, France to develop Olfactotherapy, based on the link between smells and memories, which is now used in several hospitals to help patients with brain injuries, stroke victims and Alzheimer's patients with memory impairment or of language.
In 2016, IFF joined the Well Living Lab as a Sustaining Alliance Member. The Well Living Lab is a collaboration of the Mayo Clinic and Delos Innovate Well that is seeking to, among other things, study indoor environments and create healthier indoor spaces.
In 2017, IFF Lucas Meyer Cosmetics invested in Bio ForeXtra to expand its raw material access.
IFF is a member of the European Flavour Association.
Controversies
IFF has been involved in several lawsuits relating to cases of bronchiolitis obliterans allegedly resulting from exposure to diacetyl in butter flavorings by workers at the Gilster-Mary Lee popcorn plant in Jasper, Missouri. The plaintiffs claim the manufacturers knew about the dangers of the butter flavoring used in the popcorn factory but failed to give a warning. The defendants said they were unaware of the risk and suggested there was not enough evidence to prove their product had caused the disease. Several suits have already been settled amounting to almost $53 million in damages.
In the Murray Hill neighborhood of Jacksonville, Florida an IFF plant is accused of emitting a "vile" chemical-like odor for years. The years long complaints over the emissions of the odors from the plant has caused a class-action lawsuit and a cease and desist against the plant.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
IFF Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
IFF Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota |
|---|---|
| 18 czerwca 2026 | $0,4000 |
| 20 marca 2026 | $0,4000 |
| 19 grudnia 2025 | $0,4000 |
| 29 września 2025 | $0,4000 |
| 20 czerwca 2025 | $0,4000 |
| 21 marca 2025 | $0,4000 |
| 20 grudnia 2024 | $0,4000 |
| 20 września 2024 | $0,4000 |
| 21 czerwca 2024 | $0,4000 |
| 21 marca 2024 | $0,4000 |
| 27 grudnia 2023 | $0,8100 |
| 21 września 2023 | $0,8100 |
| 22 czerwca 2023 | $0,8100 |
| 23 marca 2023 | $0,8100 |
| 27 grudnia 2022 | $0,8100 |
| 22 września 2022 | $0,8100 |
| 23 czerwca 2022 | $0,7900 |
| 24 marca 2022 | $0,7900 |
| 27 grudnia 2021 | $0,7900 |
| 23 września 2021 | $0,7900 |
IFF Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 7 29,2%
- Kup 11 45,8%
- Trzymaj 6 25,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
18 analityków · 2026-08-13Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $0.82 | $1.13 | -0.31% |
| 31 marca 2026 | $1.25 | $1.08 | 0.17% |
| 31 grudnia 2025 | $0.80 | $0.83 | -0.04% |
| 30 września 2025 | $1.05 | $1.02 | 0.03% |
| 30 czerwca 2025 | $1.15 | $1.13 | 0.02% |
| 31 marca 2025 | $1.20 | $1.15 | 0.05% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| IFF | $17.23B | -47.8 | -5.2% | -3.3% | -2.6% | 36.2% |
| SHW | $80.26B | 31.6 | 2.1% | 10.9% | 57.1% | 48.9% |
| ECL | $74.03B | 36.1 | 2.2% | 12.9% | 22.4% | — |
| PPG | $22.89B | 14.8 | 0.19% | 9.9% | 21.4% | — |
| DD | — | -21.6 | 1.9% | -11.4% | -4.2% | — |
| ALB | — | -24.6 | -4.4% | — | — | — |
| RPM | $13.53B | 20.5 | 6.7% | 8.4% | 21.3% | 41.4% |
| SOLS | $7.71B | 32.6 | 3.1% | 6.1% | 10.2% | — |
| ESI | $6.74B | 31.6 | 3.8% | 7.5% | 7.5% | 42.0% |
| NEU | $6.46B | 15.5 | -2.2% | 15.4% | 24.7% | 31.5% |
| EMN | $14.29B | 15.6 | -6.7% | 5.4% | 8.1% | 21.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.89B | $11.48B | $11.48B | $12.44B | $11.66B | $5.08B | $5.14B | $3.98B | $3.40B | $3.12B | $3.02B | $3.09B | |
| Cost of Revenue | $6.95B | $7.36B | $7.80B | $8.29B | $7.92B | $3.00B | $3.03B | $2.29B | $1.93B | $1.72B | $1.67B | $1.73B | |
| Gross Profit | $3.94B | $4.12B | $3.68B | $4.15B | $3.73B | $2.09B | $2.11B | $1.68B | $1.47B | $1.40B | $1.35B | $1.36B | |
| R&D Expense | $694M | $671M | $636M | $603M | $629M | $357M | $346M | $312M | $295M | $259M | $246M | $254M | |
| SG&A Expense | $1.83B | $2.00B | $1.79B | $1.77B | $1.75B | $949M | $876M | $707M | $570M | $573M | $495M | $508M | |
| Operating Income | $-382M | $766M | $-2.11B | $-1.33B | $585M | $566M | $665M | $584M | $553M | $553M | $588M | $592M | |
| Interest Expense | · | · | $380M | $336M | $289M | $132M | $138M | $133M | $65M | $53M | $46M | $46M | |
| Interest Income | $19M | $15M | $5M | $15M | $8M | · | · | · | · | · | · | · | |
| Other Non-op | $-65M | $-182M | $-5M | $26M | $58M | $7M | $30M | $35M | $50M | $24M | $-3M | $3M | |
| Pretax Income | $-412M | $308M | $-2.52B | $-1.62B | $354M | $441M | $557M | $448M | $537M | $524M | $539M | $549M | |
| Income Tax | $-53M | $41M | $69M | $239M | $75M | $74M | $97M | $108M | $241M | $119M | $120M | $135M | |
| Net Income | $-359M | $267M | $-2.59B | $-1.86B | $279M | $367M | $460M | $340M | $296M | $405M | $419M | $415M | |
| EPS (Basic) | $-1.41 | $1.04 | $-10.14 | $-7.32 | $1.11 | $3.25 | $4.05 | $3.81 | $3.73 | $5.07 | $5.19 | $5.09 | |
| EPS (Diluted) | $-1.41 | $1.04 | $-10.14 | $-7.32 | $1.10 | $3.21 | $4.00 | $3.79 | $3.72 | $5.05 | $5.16 | $5.06 | |
| Shares (Basic) | 256,000,000 | 256,000,000 | 255,000,000 | 255,000,000 | 243,000,000 | 112,000,000 | 112,000,000 | 87,551,000 | 79,070,000 | 79,648,000 | 80,449,000 | 80,936,000 | |
| Shares (Diluted) | 256,000,000 | 256,000,000 | 255,000,000 | 255,000,000 | 243,000,000 | 114,000,000 | 113,000,000 | 88,121,000 | 79,370,000 | 79,981,000 | 80,891,000 | 81,494,000 | |
| EBITDA | $580M | $1.78B | $-968M | $-147M | $1.74B | $892M | $989M | $758M | $699M | $670M | $678M | $682M |
Bilans 28
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $590M | $469M | $703M | $483M | $711M | $650M | $607M | $635M | $368M | $324M | $182M | $479M | |
| Receivables | $1.29B | $1.62B | $1.73B | $1.82B | $1.91B | $929M | $876M | $63M | $664M | $551M | $538M | $494M | |
| Inventory | $1.51B | $2.13B | $2.48B | $3.15B | $2.52B | $1.13B | $1.12B | $1.08B | $649M | $592M | $572M | $569M | |
| Prepaid Expense | $161M | $159M | $184M | $144M | $160M | $100M | $111M | $91M | · | · | · | · | |
| Other Current Assets | $742M | $686M | $875M | $770M | $728M | $342M | $319M | $277M | $215M | $142M | $145M | $141M | |
| Current Assets | $5.59B | $7.97B | $6.29B | $7.43B | $6.99B | $3.06B | $2.94B | $2.94B | $1.90B | $1.61B | $1.44B | $1.71B | |
| PP&E (Net) | $2.69B | $3.74B | $4.24B | $4.20B | $4.37B | $1.46B | $1.39B | $1.24B | $881M | $776M | $733M | $720M | |
| PP&E (Gross) | $4.84B | $6.17B | $6.64B | $6.18B | $6.16B | $2.93B | $2.69B | $2.49B | $2.09B | $1.91B | $1.81B | $1.77B | |
| Accum. Depreciation | $2.15B | $2.43B | $2.40B | $1.98B | $1.79B | $1.47B | $1.30B | $1.25B | $1.21B | $1.14B | $1.08B | $1.05B | |
| Goodwill | $8.23B | $9.07B | $10.63B | $13.37B | $16.43B | $5.59B | $5.50B | $5.38B | $1.16B | $1.00B | $941M | $675M | |
| Intangibles | $3.96B | $6.45B | $8.36B | $9.08B | $10.51B | $2.73B | $2.85B | $3.04B | $416M | $366M | $306M | $77M | |
| Other Non-current Assets | $954M | $907M | $764M | $689M | $616M | $418M | $608M | $289M | $250M | $128M | $118M | $129M | |
| Total Assets | $25.54B | $28.72B | $30.98B | $35.52B | $39.66B | $13.55B | $13.29B | $12.89B | $4.60B | $4.02B | $3.70B | $3.49B | |
| Accounts Payable | $933M | $1.28B | $1.38B | $1.42B | $1.53B | $556M | $510M | $471M | $338M | $275M | $286M | $216M | |
| Short-term Debt | $314M | $0 | $0 | $187M | $324M | $0 | · | · | · | $0 | · | · | |
| Current Liabilities | $3.93B | $4.35B | $3.76B | $3.73B | $3.63B | $1.90B | $1.55B | $1.13B | $769M | $898M | $725M | $519M | |
| Capital Leases | $533M | $550M | $642M | $672M | $670M | $265M | $253M | · | · | · | · | · | |
| Deferred Tax | $840M | $1.59B | $1.94B | $2.28B | $2.52B | $593M | $641M | $656M | $51M | · | · | $12M | |
| Other Non-current Liabilities | $573M | $627M | $560M | $491M | $462M | $268M | $502M | $248M | $191M | $137M | $161M | $118M | |
| Long-term Debt | $5.64B | $8.89B | $9.98B | $10.58B | $10.97B | $4.44B | $4.42B | $4.60B | $1.64B | $1.33B | $1.07B | $942M | |
| Total Debt | $6.31B | $8.98B | $10.07B | $11.16B | $11.72B | $4.41B | $4.38B | $4.55B | $1.64B | $1.33B | $1.07B | $942M | |
| Common Stock | $35M | $35M | $35M | $35M | $35M | $16M | $16M | $16M | $14M | $14M | $14M | $14M | |
| Retained Earnings | $-3.42B | $-2.65B | $-2.44B | $955M | $3.64B | $4.16B | $4.12B | $3.96B | $3.87B | $3.82B | $3.60B | $3.35B | |
| Treasury Stock | $952M | $944M | $963M | $978M | $997M | $1.02B | $1.02B | $1.03B | $1.73B | $1.68B | $1.56B | $1.45B | |
| AOCI | $-1.43B | $-2.53B | $-1.90B | $-2.20B | $-1.42B | $-698M | $-717M | $-702M | $-637M | $-680M | $-613M | $-540M | |
| Stockholders' Equity | $14.15B | $13.83B | $14.61B | $17.66B | $21.08B | $6.31B | $6.22B | $6.03B | $1.68B | $1.63B | $1.59B | $1.52B | |
| Liabilities + Equity | $25.54B | $28.72B | $30.98B | $35.52B | $39.66B | $13.55B | $13.29B | $12.89B | $4.60B | $4.02B | $3.70B | $3.49B | |
| Shares Outstanding | 255,700,000 | 255,700,000 | 255,300,000 | 254,968,463 | 254,573,984 | 106,937,990 | 106,787,299 | 106,619,202 | 78,947,381 | 79,213,037 | 80,022,291 | 80,777,590 |
Przepływy pieniężne 19
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $962M | $1.01B | $1.14B | $1.18B | $1.16B | $325M | $323M | $174M | $118M | $102M | $90M | $89M | |
| Stock-based Comp | $88M | $77M | $65M | $49M | $54M | $36M | $34M | $29M | $27M | $25M | $23M | $23M | |
| Deferred Tax | $-270M | $-323M | $-371M | $-237M | $-236M | $-68M | $-59M | $19M | $59M | $14M | $13M | $23M | |
| Amort. of Intangibles | $568M | $610M | $680M | $727M | $732M | $193M | $193M | $76M | $35M | $24M | $15M | $7M | |
| Restructuring | $70M | $29M | $68M | $12M | $41M | $17M | $30M | $5M | $20M | $-1M | $8M | $6M | |
| Other Non-cash | $429M | $35M | $3.16B | $1.27B | $184M | $53M | $-60M | $-125M | $-108M | $-11M | $-111M | $-32M | |
| Operating Cash Flow | $850M | $1.07B | $1.46B | $397M | $1.44B | $714M | $699M | $438M | $391M | $550M | $467M | $518M | |
| CapEx | $594M | $463M | $503M | $504M | $393M | $192M | $236M | $170M | $129M | $126M | $101M | $143M | |
| Investing Cash Flow | $2.27B | $326M | $558M | $745M | $-18M | $-187M | $-226M | $-5.01B | $-300M | $-355M | $-577M | $-221M | |
| Debt Issued | · | · | $0 | $0 | $3M | $200M | $0 | $3.26B | $498M | $556M | $0 | $4M | |
| Net Debt Issued | $-2.91B | $-1.03B | $-655M | $-300M | $-825M | $-147M | $-155M | $2.88B | $248M | $431M | $0 | $4M | |
| Stock Repurchased | $38M | $0 | $0 | · | · | $0 | $0 | $15M | $58M | $127M | $122M | $88M | |
| Net Stock Activity | $-38M | · | · | · | · | $0 | $0 | $-15M | $-58M | $-127M | $-122M | $-88M | |
| Dividends Paid | $409M | $514M | $826M | $810M | $667M | $323M | $314M | $230M | $206M | $185M | $159M | $133M | |
| Financing Cash Flow | $-3.09B | $-1.61B | $-1.85B | $-1.23B | $-1.30B | $-512M | $-505M | $4.87B | $-43M | $-34M | $-165M | $-202M | |
| Net Change in Cash | $119M | $-264M | $183M | $-164M | $56M | $36M | $-25M | $280M | $44M | $142M | $-297M | $73M | |
| Taxes Paid | $329M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $256M | $607M | $936M | $-107M | $1.04B | $522M | $463M | $267M | $262M | $409M | $333M | $375M | |
| Levered FCF | · | · | $549M | $-492M | $816M | $413M | $349M | $167M | $226M | $368M | $297M | $340M |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.2% | 35.9% | 32.1% | 33.4% | 32.0% | 41.0% | 41.1% | 42.3% | 43.5% | 44.9% | 44.7% | 44.1% | |
| Operating Margin | -3.5% | 6.7% | -18.4% | -10.7% | 5.0% | 11.1% | 12.9% | 14.7% | 17.1% | 18.2% | 19.5% | 19.2% | |
| Net Margin | -3.3% | 2.1% | -22.3% | -15.0% | 2.4% | 7.2% | 8.9% | 8.5% | 8.7% | 13.0% | 13.9% | 13.4% | |
| Pretax Margin | -3.8% | 2.4% | -21.9% | -13.1% | 3.0% | 8.7% | 10.8% | 11.3% | 15.8% | 16.8% | 17.8% | 17.8% | |
| EBITDA Margin | 5.3% | 15.5% | -8.4% | -1.2% | 14.9% | 17.5% | 19.2% | 19.1% | 20.6% | 21.5% | 22.4% | 22.1% | |
| ROA | -1.3% | 0.83% | -7.7% | -5.0% | 1.1% | 2.7% | 3.5% | 3.9% | 6.9% | 10.5% | 11.6% | 12.2% | |
| ROE | -2.6% | 1.7% | -15.9% | -9.6% | 2.0% | 5.9% | 7.5% | 8.8% | 17.9% | 25.2% | 27.0% | 27.8% | |
| ROIC | -1.6% | 3.0% | -8.7% | -5.3% | 1.4% | 4.4% | 5.2% | 4.2% | 9.6% | 14.9% | 17.2% | 18.2% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.8 | 1.7 | 2.0 | 1.9 | 1.6 | 1.9 | 2.6 | 2.5 | 1.8 | 2.0 | 3.3 | |
| Quick Ratio | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 | 0.8 | 0.4 | 0.6 | 0.5 | 0.4 | 0.2 | 0.9 | |
| Debt / Equity | 0.4 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.8 | 1.0 | 0.8 | 0.7 | 0.6 | |
| LT Debt / Equity | 0.3 | 0.5 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 | 1.0 | 0.7 | 0.6 | 0.6 | |
| Interest Coverage | · | · | -5.6 | -3.9 | 2.0 | 4.3 | 4.8 | 4.4 | 8.9 | 10.7 | 12.8 | 12.9 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.8 | 0.8 | 0.8 | 0.9 | |
| Inventory Turnover | 3.2 | 3.2 | 2.8 | 2.9 | 4.3 | 2.7 | 2.8 | 2.7 | 3.1 | 3.0 | 2.9 | 3.1 | |
| Receivables Turnover | 6.5 | 6.9 | 6.5 | 6.7 | 8.2 | 5.6 | 82.8 | · | · | · | · | · |
Stopy Wzrostu 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.2% | 0.04% | -7.7% | 6.7% | 129.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -4.3% | -0.49% | 31.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -65.7% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -1.8% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -24.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -1.5% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.8% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.89B | $11.48B | $11.48B | $12.44B | $11.66B | $5.08B | $5.14B | $3.98B | $3.40B | $3.12B | $3.02B | $3.09B | |
| Net Income TTM | $-359M | $267M | $-2.59B | $-1.86B | $279M | $367M | $460M | $340M | $296M | $405M | $419M | $415M | |
| Market Cap | $17.23B | $21.62B | $20.67B | $26.73B | $38.35B | $11.64B | $13.78B | $14.32B | $12.05B | $9.33B | $9.57B | $8.19B | |
| Enterprise Value | $22.95B | $30.13B | $30.04B | $37.40B | $49.36B | $15.40B | $17.55B | $18.23B | $13.32B | $10.34B | $10.46B | $8.65B | |
| P/E | -47.8 | 81.3 | -8.0 | -14.3 | 137.0 | 33.9 | 32.3 | 35.4 | 41.0 | 23.3 | 23.2 | 20.0 | |
| P/S | 1.6 | 1.9 | 1.8 | 2.1 | 3.3 | 2.3 | 2.7 | 3.6 | 3.5 | 3.0 | 3.2 | 2.7 | |
| P/B | 1.2 | 1.6 | 1.4 | 1.5 | 1.8 | 1.8 | 2.2 | 2.4 | 7.2 | 5.7 | 6.0 | 5.4 | |
| P / Tangible Book | 8.8 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 20.3 | 20.2 | 14.4 | 67.3 | 26.7 | 16.3 | 19.7 | 32.7 | 30.8 | 17.4 | 22.1 | 15.8 | |
| P / FCF | 67.3 | 35.6 | 22.1 | -249.8 | 36.7 | 22.3 | 29.8 | 53.5 | 46.0 | 22.8 | 28.8 | 21.8 | |
| EV / EBITDA | 39.6 | 16.9 | -31.0 | -254.5 | 28.4 | 17.3 | 17.8 | 24.1 | 19.0 | 15.4 | 15.4 | 12.7 | |
| EV / FCF | 89.6 | 49.6 | 32.1 | -349.6 | 47.3 | 29.5 | 37.9 | 68.2 | 50.9 | 25.3 | 31.5 | 23.1 | |
| EV / Revenue | 2.1 | 2.6 | 2.6 | 3.0 | 4.2 | 3.0 | 3.4 | 4.6 | 3.9 | 3.3 | 3.5 | 2.8 | |
| Dividend Yield | 2.4% | 2.4% | 4.0% | 3.0% | 1.7% | 2.8% | 2.3% | 1.6% | 1.7% | 2.0% | 1.7% | 1.6% | |
| Earnings Yield | -2.1% | 1.2% | -12.5% | -7.0% | 0.73% | 2.9% | 3.1% | 2.8% | 2.4% | 4.3% | 4.3% | 5.0% | |
| Payout Ratio | -113.9% | 208.1% | -32.2% | -43.5% | 239.1% | 87.8% | 68.1% | 67.8% | 69.7% | 45.6% | 37.9% | 32.1% | |
| Annual Payout | $409M | $514M | $826M | $810M | $667M | $323M | $314M | $230M | $206M | $185M | $159M | $133M |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $2.74B | $2.59B | $2.69B | $1.92B | $2.84B | $2.77B | $2.92B | $2.89B | $2.90B | $2.70B | $2.82B | $2.93B | $3.03B | $2.84B | $3.06B | |
| Cost of Revenue | $1.10B | $1.72B | $1.70B | $1.71B | $1.09B | $1.81B | $1.79B | $1.87B | $1.82B | $1.88B | $1.84B | $1.90B | $2.00B | $2.06B | $1.98B | $2.06B | |
| Gross Profit | $853M | $1.02B | $890M | $983M | $824M | $1.03B | $980M | $1.05B | $1.07B | $1.02B | $860M | $924M | $933M | $964M | $869M | $1.00B | |
| R&D Expense | $170M | $166M | $174M | $174M | $170M | $164M | $170M | $162M | $173M | $166M | $157M | $157M | $161M | $161M | $143M | $145M | |
| SG&A Expense | $437M | $427M | $469M | $421M | $409M | $461M | $517M | $495M | $493M | $490M | $444M | $444M | $445M | $454M | $440M | $413M | |
| Operating Income | $158M | $273M | $97M | $226M | $142M | $-903M | $127M | $249M | $191M | $199M | $-2.54B | $150M | $145M | $131M | $105M | $-1.99B | |
| Interest Expense | $46M | $44M | · | $48M | $61M | $71M | · | $74M | $79M | $83M | · | $90M | $101M | $100M | · | $83M | |
| Interest Income | $4M | $3M | $4M | $4M | $7M | $4M | $6M | $3M | $3M | $3M | $3M | $1M | $1M | $0 | · | · | |
| Other Non-op | $-20M | $-13M | $-21M | $-14M | $-20M | $-20M | $-138M | $-28M | $-15M | $-1M | $-8M | $9M | $11M | $-17M | $-17M | $33M | |
| Pretax Income | $64M | $209M | $-8M | $56M | $438M | $-994M | $-85M | $95M | $183M | $115M | $-2.64B | $59M | $50M | $14M | $-5M | $-2.04B | |
| Income Tax | $31M | $39M | $-13M | $15M | $-112M | $23M | $-60M | $36M | $11M | $54M | $-8M | $32M | $23M | $22M | $19M | $160M | |
| Net Income | $50M | $169M | $7M | $40M | $599M | $-1.02B | $-21M | $58M | $170M | $60M | $-2.63B | $25M | $27M | $-9M | $-18M | $-2.20B | |
| EPS (Basic) | $0.20 | $0.66 | $0.02 | $0.16 | $2.34 | $-3.98 | $-0.09 | $0.23 | $0.67 | $0.23 | $-10.31 | $0.10 | $0.11 | $-0.04 | $-0.11 | $-8.60 | |
| EPS (Diluted) | $0.20 | $0.66 | $0.03 | $0.16 | $2.33 | $-3.98 | $-0.08 | $0.23 | $0.66 | $0.23 | $-10.31 | $0.10 | $0.11 | $-0.04 | $-0.11 | $-8.60 | |
| Shares (Basic) | 255,000,000 | 256,000,000 | -512,000,000 | 256,000,000 | 256,000,000 | 256,000,000 | -510,000,000 | 256,000,000 | 255,000,000 | 255,000,000 | -510,000,000 | 255,000,000 | 255,000,000 | 255,000,000 | -510,000,000 | 255,000,000 | |
| Shares (Diluted) | 257,000,000 | 257,000,000 | -514,000,000 | 257,000,000 | 257,000,000 | 256,000,000 | -513,000,000 | 257,000,000 | 256,000,000 | 256,000,000 | -511,000,000 | 256,000,000 | 255,000,000 | 255,000,000 | -510,000,000 | 255,000,000 | |
| EBITDA | $158M | $519M | · | $226M | $198M | $-667M | · | $249M | $191M | $477M | · | $150M | $145M | $407M | · | $-1.99B |
Bilans 28
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $569M | $562M | $590M | $621M | $816M | $613M | $469M | $567M | $671M | $732M | $703M | $629M | $638M | $590M | $483M | $538M | |
| Receivables | $1.42B | $1.83B | $1.73B | $1.87B | $1.80B | $1.74B | $1.62B | $1.77B | $1.77B | $1.98B | · | $1.83B | $1.89B | $1.90B | · | $2.03B | |
| Inventory | $1.50B | $2.25B | $2.25B | $2.32B | $2.37B | $2.25B | $2.13B | $2.20B | $2.16B | $2.41B | · | $2.55B | $2.79B | $2.95B | · | $3.12B | |
| Prepaid Expense | $139M | $154M | $170M | $180M | $180M | $213M | $159M | $229M | $217M | $202M | · | $184M | $187M | $163M | · | $348M | |
| Other Current Assets | $706M | $795M | $877M | $911M | $940M | $775M | $686M | $770M | $728M | $771M | · | $890M | $898M | $789M | · | $793M | |
| Current Assets | $9.09B | $5.44B | $5.59B | $5.88B | $5.93B | $8.63B | $7.97B | $8.42B | $8.15B | $6.41B | · | $6.39B | $6.44B | $7.44B | · | $6.49B | |
| PP&E (Net) | $2.67B | $4.00B | $4.03B | $3.87B | $3.90B | $3.77B | $3.74B | $3.77B | $3.76B | $4.14B | · | $4.13B | $4.22B | $4.22B | · | $4.05B | |
| PP&E (Gross) | $4.92B | $6.86B | $6.83B | $6.61B | $6.62B | $6.33B | $6.17B | $6.27B | $6.14B | $6.61B | · | $6.37B | $6.40B | $6.31B | · | $6.03B | |
| Accum. Depreciation | $2.26B | $2.87B | $2.80B | $2.74B | $2.71B | $2.56B | $2.43B | $2.49B | $2.38B | $2.47B | · | $2.24B | $2.19B | $2.08B | · | $1.98B | |
| Goodwill | $8.14B | $8.22B | $8.27B | $8.26B | $8.28B | $8.03B | $9.07B | $9.35B | $9.28B | $10.54B | $10.63B | $13.03B | $13.50B | $13.46B | $13.37B | $13.30B | |
| Intangibles | $3.73B | $5.87B | $6.04B | $6.18B | $6.43B | $6.38B | $6.45B | $6.77B | $6.88B | $8.12B | · | $8.38B | $8.81B | $8.97B | · | $9.39B | |
| Other Non-current Assets | $1.02B | $1.05B | $1.02B | $982M | $955M | $869M | $907M | $968M | $805M | $737M | · | $763M | $754M | $744M | · | $663M | |
| Total Assets | $25.15B | $25.14B | $25.54B | $25.77B | $26.12B | $28.27B | $28.72B | $29.93B | $29.54B | $30.64B | · | $33.40B | $34.46B | $35.47B | · | $34.54B | |
| Accounts Payable | $1.06B | $1.37B | $1.29B | $1.28B | $1.35B | $1.32B | $1.28B | $1.21B | $1.27B | $1.35B | · | $1.11B | $1.23B | $1.20B | · | $1.53B | |
| Short-term Debt | $50M | $154M | $314M | $370M | · | $292M | $0 | $0 | $189M | $836M | · | $0 | $159M | $588M | · | $204M | |
| Current Liabilities | $4.41B | $3.65B | $3.93B | $4.07B | $3.18B | $4.61B | $4.35B | $3.22B | $3.42B | $3.82B | · | $3.68B | $3.93B | $4.87B | · | $3.63B | |
| Capital Leases | · | · | $533M | · | · | · | $550M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $819M | $1.35B | $1.38B | $1.34B | $1.39B | $1.54B | $1.59B | $1.87B | $1.83B | $1.92B | · | $2.13B | $2.18B | $2.23B | · | $2.28B | |
| Other Non-current Liabilities | $551M | $548M | $582M | $611M | $680M | $592M | $627M | $613M | $572M | $527M | · | $475M | $504M | $494M | · | $472M | |
| Long-term Debt | $5.70B | $5.82B | $5.64B | $6.05B | $6.18B | $9.29B | $8.98B | $9.10B | $9.38B | $10.30B | · | $10.30B | $10.57B | $11.29B | · | $10.77B | |
| Total Debt | $5.75B | $5.97B | · | $6.42B | $6.18B | $9.58B | · | $9.10B | $9.57B | $11.13B | · | $10.30B | $10.73B | $11.88B | · | $10.98B | |
| Common Stock | $35M | $35M | $35M | $35M | $35M | $35M | $35M | $35M | $35M | $35M | · | $35M | $35M | $35M | · | $35M | |
| Retained Earnings | $-3.40B | $-3.35B | $-3.42B | $-3.35B | $-3.21B | $-3.73B | $-2.65B | $-2.46B | $-2.41B | $-2.48B | · | $378M | $560M | $739M | · | $1.19B | |
| Treasury Stock | $998M | $986M | $952M | $915M | $917M | $942M | $944M | $945M | $946M | $961M | · | $964M | $966M | $973M | · | $979M | |
| AOCI | $-1.59B | $-1.51B | $-1.43B | $-1.46B | $-1.42B | $-2.12B | $-2.53B | $-1.76B | $-2.31B | $-2.19B | · | $-2.34B | $-1.86B | $-1.89B | · | $-3.19B | |
| Stockholders' Equity | $13.98B | $14.12B | $14.15B | $14.24B | $14.40B | $13.18B | $13.83B | $14.78B | $14.25B | $14.29B | · | $16.98B | $17.62B | $17.76B | · | $16.89B | |
| Liabilities + Equity | $25.15B | $25.14B | $25.54B | $25.77B | $26.12B | $28.27B | $28.72B | $29.93B | $29.54B | $30.64B | · | $33.40B | $34.46B | $35.47B | · | $34.54B | |
| Shares Outstanding | 255,300,000 | 255,200,000 | 255,700,000 | 256,300,000 | 256,300,000 | 255,700,000 | 255,700,000 | 255,700,000 | 255,656,988 | 255,319,533 | · | 255,268,628 | 255,221,731 | 255,067,476 | · | 254,949,630 |
Przepływy pieniężne 18
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $218M | $246M | $237M | $247M | $242M | $236M | $243M | $248M | $246M | $278M | $287M | $292M | $287M | $276M | $282M | $293M | |
| Stock-based Comp | $35M | $16M | $16M | $21M | $32M | $19M | $18M | $16M | $25M | $18M | $15M | $18M | $20M | $12M | $12M | $12M | |
| Deferred Tax | $-22M | $-15M | $-57M | $-50M | $-102M | $-61M | $-180M | $-66M | $-68M | $-9M | $-312M | $-32M | $1M | $-28M | $-15M | $-44M | |
| Amort. of Intangibles | $82M | $146M | $134M | $146M | $82M | $143M | $143M | $146M | $153M | $168M | $167M | $170M | $172M | $171M | $175M | $182M | |
| Restructuring | $6M | $6M | $16M | $16M | $20M | $17M | $23M | $1M | $2M | $3M | $7M | $2M | $7M | $52M | $7M | $-4M | |
| Other Non-cash | · | $-159M | · | · | · | $951M | · | · | · | $-248M | · | · | · | $-124M | · | · | |
| Operating Cash Flow | $422M | $257M | $318M | $164M | $241M | $127M | $389M | $345M | $237M | $99M | $660M | $420M | $248M | $127M | $208M | $289M | |
| CapEx | $136M | $165M | $188M | $132M | $95M | $179M | $160M | $103M | $82M | $118M | $113M | $100M | $115M | $175M | $160M | $108M | |
| Investing Cash Flow | $-156M | $23M | $-157M | $-115M | $2.70B | $-157M | $-281M | $-57M | $742M | $-78M | $-80M | $86M | $719M | $-167M | $-142M | $1.23B | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | $0 | · | · | · | $-16M | · | · | · | $-833M | · | · | · | · | · | · | |
| Stock Repurchased | $36M | $35M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-35M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $102M | $102M | $103M | $102M | $102M | $102M | $103M | $102M | $102M | $207M | $207M | $206M | $207M | $206M | $206M | $202M | |
| Financing Cash Flow | $-264M | $-301M | $-200M | $-237M | $-2.82B | $169M | $-162M | $-421M | $-1.06B | $40M | $-558M | $-427M | $-944M | $78M | $-142M | $-1.46B | |
| Net Change in Cash | $7M | $-28M | $-31M | $-195M | $166M | $179M | $-98M | $-105M | $-97M | $36M | $73M | $10M | $35M | $65M | $-3M | $-18M | |
| Free Cash Flow | · | $92M | · | · | · | $-52M | · | · | · | $-19M | · | · | · | $-48M | · | · | |
| Levered FCF | · | $56M | · | · | · | $-125M | · | · | · | $-63M | · | · | · | $15M | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.6% | 37.1% | · | 36.5% | 37.3% | 36.4% | · | 36.0% | 37.0% | 35.3% | · | 32.8% | 31.9% | 31.9% | · | 32.7% | |
| Operating Margin | 8.1% | 10.0% | · | 8.4% | 7.2% | -31.8% | · | 8.5% | 6.6% | 6.9% | · | 5.3% | 5.0% | 4.3% | · | -64.8% | |
| Net Margin | 2.6% | 6.2% | · | 1.5% | 22.1% | -35.8% | · | 2.0% | 5.9% | 2.1% | · | 0.89% | 0.92% | -0.30% | · | -71.7% | |
| Pretax Margin | 3.3% | 7.6% | · | 2.1% | 19.3% | -35.0% | · | 3.2% | 6.3% | 4.0% | · | 2.1% | 1.7% | 0.46% | · | -66.4% | |
| EBITDA Margin | 8.1% | 18.9% | · | 8.4% | 7.2% | -23.5% | · | 8.5% | 6.6% | 16.4% | · | 5.3% | 5.0% | 13.5% | · | -64.8% | |
| ROA | 0.20% | 0.63% | · | 0.14% | 2.2% | -3.5% | · | 0.19% | 0.53% | 0.18% | · | 0.07% | 0.07% | -0.02% | · | -5.9% | |
| ROE | 0.35% | 1.2% | · | 0.28% | 4.3% | -7.4% | · | 0.37% | 1.1% | 0.37% | · | 0.15% | 0.14% | -0.05% | · | -11.5% | |
| ROIC | 0.41% | 1.1% | · | 0.80% | 1.1% | -4.1% | · | 0.66% | 0.75% | 0.42% | · | 0.25% | 0.28% | -0.25% | · | -7.7% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.5 | · | 1.4 | 1.9 | 1.9 | · | 2.6 | 2.4 | 1.7 | · | 1.7 | 1.6 | 1.5 | · | 1.8 | |
| Quick Ratio | 0.5 | 0.7 | · | 0.6 | 0.8 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.5 | · | 0.7 | |
| Debt / Equity | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.7 | · | 0.6 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | |
| Interest Coverage | 3.4 | 6.2 | · | 4.7 | 3.2 | -12.7 | · | 3.4 | 2.4 | 2.4 | · | 1.4 | 1.2 | 1.2 | · | -23.9 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.6 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Receivables Turnover | 1.2 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.5 | · | 1.5 | 1.4 | 1.5 | · | 1.5 |
Wycena (TTM) 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.31B | $11.04B | · | $11.07B | $11.30B | $11.43B | · | $11.53B | $11.54B | $11.68B | · | $11.84B | $12.33B | $12.62B | · | $12.67B | |
| Net Income TTM | $858M | $-197M | · | $-308M | $-178M | $-730M | · | $313M | $282M | $103M | · | $-2.15B | $-2.07B | $-1.85B | · | $-1.65B | |
| Market Cap | $20.22B | $18.51B | · | $15.77B | $18.85B | $19.84B | · | $26.83B | $24.34B | $21.95B | · | $17.40B | $20.31B | $23.46B | · | $23.16B | |
| Enterprise Value | $25.40B | $23.92B | · | $21.57B | $24.22B | $28.81B | · | $35.36B | $33.24B | $32.36B | · | $27.07B | $30.40B | $34.75B | · | $33.60B | |
| P/E | 23.6 | -93.0 | · | -50.9 | -103.6 | -27.1 | · | 86.0 | 86.6 | 215.0 | · | -8.1 | -9.8 | -12.7 | · | -14.1 | |
| P/S | 2.2 | 1.7 | · | 1.4 | 1.7 | 1.7 | · | 2.3 | 2.1 | 1.9 | · | 1.5 | 1.6 | 1.9 | · | 1.8 | |
| P/B | 1.4 | 1.3 | · | 1.1 | 1.3 | 1.5 | · | 1.8 | 1.7 | 1.5 | · | 1.0 | 1.2 | 1.3 | · | 1.4 | |
| P / Tangible Book | 9.6 | 561.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 72.0 | · | · | · | 156.3 | · | · | · | 221.8 | · | · | · | 184.7 | · | · | |
| P / FCF | · | 201.2 | · | · | · | -381.6 | · | · | · | -1155.5 | · | · | · | -488.7 | · | · | |
| EV / EBITDA | 160.8 | 46.1 | · | 95.4 | 122.3 | -43.2 | · | 142.0 | 174.0 | 67.8 | · | 180.5 | 209.7 | 85.4 | · | -16.9 | |
| EV / FCF | · | 260.0 | · | · | · | -554.1 | · | · | · | -1703.0 | · | · | · | -723.9 | · | · | |
| EV / Revenue | 2.7 | 2.2 | · | 1.9 | 2.1 | 2.5 | · | 3.1 | 2.9 | 2.8 | · | 2.3 | 2.5 | 2.8 | · | 2.7 | |
| Earnings Yield | 4.2% | -1.1% | · | -2.0% | -0.97% | -3.7% | · | 1.2% | 1.2% | 0.47% | · | -12.4% | -10.2% | -7.9% | · | -7.1% | |
| Payout Ratio | · | 60.4% | · | · | · | -10.0% | · | · | · | 345.0% | · | · | · | -2288.9% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $10.89B | $11.48B | $11.48B | $12.44B | $11.66B |
| Marża Brutto % | 36.2% | 35.9% | 32.1% | 33.4% | 32.0% |
| Marża Operacyjna % | -3.5% | 6.7% | -18.4% | -10.7% | 5.0% |
| Zysk netto | $-359M | $267M | $-2.59B | $-1.86B | $279M |
| Rozwodniony EPS | $-1.41 | $1.04 | $-10.14 | $-7.32 | $1.10 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.4 | 0.6 | 0.7 | 0.6 | 0.6 |
| Wskaźnik bieżący | 1.4 | 1.8 | 1.7 | 2.0 | 1.9 |
| Wskaźnik Szybkości | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $256M | $607M | $936M | $-107M | $1.04B |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 820 emitentów · $16.9B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 117 (+19 vs poprzedni kw.) | 48 (-31 vs poprzedni kw.) | 272 (+3 vs poprzedni kw.) | 228 (+28 vs poprzedni kw.) | +44.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Dodge & Cox | $2 931 697 471 | 37 007 037 | 17,38% | Akcje |
| Freemont Capital Pte Ltd | $2 008 732 503 | 25 356 381 | 11,91% | Akcje |
| VANGUARD GROUP INC | $1 871 694 240 | 27 774 065 | 11,10% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 287 737 499 | 16 255 207 | 7,63% | Akcje |
| STATE STREET CORP | $982 388 241 | 12 340 998 | 5,82% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $919 640 105 | 11 608 686 | 5,45% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $471 284 813 | 5 975 838 | 2,79% | Akcje |
| First Pacific Advisors, LP | $432 151 517 | 5 455 081 | 2,56% | Akcje |
| ICAHN CARL C | $338 665 500 | 4 275 000 | 2,01% | Akcje |
| Eurizon Capital SGR S.p.A. | $254 339 992 | 3 226 394 | 1,51% | Akcje |
| AMERIPRISE FINANCIAL INC | $219 832 672 | 2 774 801 | 1,30% | Akcje |
| CONTINENTAL GRAIN CO | $212 525 871 | 2 682 730 | 1,26% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $201 592 956 | 2 544 723 | 1,20% | Akcje |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $177 931 289 | 2 246 040 | 1,05% | Akcje |
| Ilex Capital Partners (UK) LLP | $156 816 782 | 1 979 510 | 0,93% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $145 954 453 | 1 842 394 | 0,87% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $123 491 268 | 1 558 841 | 0,73% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $119 131 194 | 1 503 802 | 0,71% | Akcje |
| Capital International Investors | $115 673 400 | 1 460 154 | 0,69% | Akcje |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $113 924 618 | 1 438 079 | 0,68% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $112 779 652 | 1 423 626 | 0,67% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $111 854 461 | 1 476 627 | 0,66% | Akcje |
| NORGES BANK | $109 017 732 | 1 376 139 | 0,65% | Akcje |
| River Road Asset Management, LLC | $108 130 784 | 1 364 943 | 0,64% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $107 310 144 | 1 354 584 | 0,64% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $105 749 533 | 1 457 609 | 0,63% | Akcje |
| BANK OF AMERICA CORP /DE/ | $89 067 362 | 1 124 304 | 0,53% | Akcje |
| STALEY CAPITAL ADVISERS INC | $84 525 997 | 1 066 978 | 0,50% | Akcje |
| Clearbridge Investments, LLC | $82 220 564 | 1 037 876 | 0,49% | Akcje |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $80 422 970 | 1 015 185 | 0,48% | Akcje |
| Quantinno Capital Management LP | $72 524 267 | 915 479 | 0,43% | Akcje |
| DAVENPORT & Co LLC | $70 561 175 | 890 699 | 0,42% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $70 129 109 | 885 245 | 0,42% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $68 222 680 | 861 180 | 0,40% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $58 842 476 | 742 773 | 0,35% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $56 269 728 | 710 297 | 0,33% | Akcje |
| Swiss National Bank | $55 636 127 | 702 299 | 0,33% | Akcje |
| GOLDMAN SACHS GROUP INC | $55 456 659 | 700 034 | 0,33% | Akcje |
| Pictet Asset Management Holding SA | $49 365 864 | 623 149 | 0,29% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $46 372 774 | 585 367 | 0,27% | Akcje |
| BlackRock, Inc. | $46 067 460 | 581 513 | 0,27% | Akcje |
| Vanguard Global Advisers, LLC | $43 719 775 | 551 878 | 0,26% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $43 617 264 | 550 584 | 0,26% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $41 703 230 | 526 423 | 0,25% | Akcje |
| DEPRINCE RACE & ZOLLO INC | $37 245 428 | 513 376 | 0,22% | Akcje |
| RHUMBLINE ADVISERS | $37 158 354 | 469 053 | 0,22% | Akcje |
| PFA Pension, Forsikringsaktieselskab | $33 744 327 | 425 957 | 0,20% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $32 420 953 | 424 636 | 0,19% | Akcje |
| Gotham Asset Management, LLC | $31 903 875 | 402 725 | 0,19% | Akcje |
| California Public Employees Retirement System | $31 432 357 | 396 773 | 0,19% | Akcje |
| COOKE & BIELER LP | $30 885 026 | 389 864 | 0,18% | Akcje |
| OFI INVEST ASSET MANAGEMENT | $28 869 465 | 416 643 | 0,17% | Akcje |
| BARCLAYS PLC | $28 823 405 | 363 840 | 0,17% | Akcje |
| Douglas Lane & Associates, LLC | $28 775 794 | 363 239 | 0,17% | Akcje |
| Swedbank AB | $26 077 878 | 329 183 | 0,15% | Akcje |
| TRAN CAPITAL MANAGEMENT, L.P. | $25 935 994 | 327 392 | 0,15% | Akcje |
| FMR LLC | $25 439 940 | 321 130 | 0,15% | Akcje |
| ZWJ INVESTMENT COUNSEL INC | $25 409 928 | 320 751 | 0,15% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $25 299 354 | 319 297 | 0,15% | Akcje |
| Zurich Insurance Group Ltd/FI | $23 931 649 | 302 091 | 0,14% | Akcje |
| STRS OHIO | $23 779 943 | 300 176 | 0,14% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $21 849 589 | 275 809 | 0,13% | Akcje |
| Legal & General Group Plc | $21 701 053 | 273 934 | 0,13% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $21 441 064 | 295 535 | 0,13% | Akcje |
| Portolan Capital Management, LLC | $21 328 321 | 269 229 | 0,13% | Akcje |
| Jain Global LLC | $20 684 184 | 261 098 | 0,12% | Akcje |
| BROWN BROTHERS HARRIMAN & CO | $20 469 497 | 258 388 | 0,12% | Akcje |
| KLCM Advisors, Inc. | $20 406 517 | 257 593 | 0,12% | Akcje |
| Leith Wheeler Investment Counsel Ltd. | $20 300 440 | 256 254 | 0,12% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $20 199 444 | 278 421 | 0,12% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $19 687 544 | 248 522 | 0,12% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $18 903 910 | 247 401 | 0,11% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $18 469 192 | 233 138 | 0,11% | Akcje |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | $18 207 053 | 229 829 | 0,11% | Akcje |
| WILKINS INVESTMENT COUNSEL INC | $18 166 017 | 229 311 | 0,11% | Akcje |
| EXCHANGE TRADED CONCEPTS, LLC | $18 104 384 | 228 533 | 0,11% | Akcje |
| Ruffer LLP | $18 065 814 | 228 297 | 0,11% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $18 022 550 | 227 500 | 0,11% | Akcje |
| Covea Finance | $17 926 535 | 226 288 | 0,11% | Akcje |
| Alyeska Investment Group, L.P. | $17 665 030 | 222 987 | 0,10% | Akcje |
| AVIVA PLC | $17 615 359 | 222 360 | 0,10% | Akcje |
| ARGENT CAPITAL MANAGEMENT LLC | $17 552 656 | 221 568 | 0,10% | Akcje |
| Redwood Grove Capital, LLC | $17 403 208 | 219 682 | 0,10% | Akcje |
| Exane Asset Management | $16 787 288 | 185 402 | 0,10% | Akcje |
| CANTOR FITZGERALD INVESTMENT ADVISORS L.P. | $16 130 130 | 203 612 | 0,10% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $15 558 808 | 196 400 | 0,09% | Opcja kupna |
| First Eagle Investment Management, LLC | $14 669 563 | 185 175 | 0,09% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14 576 480 | 184 000 | 0,09% | Opcja sprzedaży |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $14 468 741 | 182 640 | 0,09% | Akcje |
| APG Asset Management N.V. | $14 104 320 | 203 553 | 0,08% | Akcje |
| Cubist Systematic Strategies, LLC | $13 155 837 | 213 776 | 0,08% | Akcje |
| PRUDENTIAL FINANCIAL INC | $13 028 838 | 164 464 | 0,08% | Akcje |
| BW Gestao de Investimentos Ltda. | $12 419 874 | 156 777 | 0,07% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $12 151 952 | 153 395 | 0,07% | Akcje |
| Lighthouse Investment Partners, LLC | $12 081 653 | 152 508 | 0,07% | Akcje |
| Russell Investments Group, Ltd. | $12 026 072 | 151 806 | 0,07% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $11 694 615 | 147 622 | 0,07% | Akcje |
| MORGAN STANLEY | $11 260 252 | 142 139 | 0,07% | Akcje |
| Corient Private Wealth LP | $10 811 467 | 136 467 | 0,06% | Akcje |
| ROYAL LONDON ASSET MANAGEMENT LTD | $10 657 783 | 134 534 | 0,06% | Akcje |
Insiderzy spółki 98 insiderów · 27 dyrektorzy generalni · 9 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Richard A Goldstein | Chairman & CEO | 5 maja 2006 M | 213 674 | 0 | 0 | $0 |
| Alison A Cornell | EVP & CFO | 2 maja 2016 A | 5 422 | 0 | 0 | $0 |
| Kevin C Berryman | EVP & Chief Financial Officer | 15 grudnia 2014 A | 56 105 | 0 | 0 | $0 |
| Douglas J Wetmore | Senior VP, CFO and Treasurer | 28 sierpnia 2008 A | 82 518 | 0 | 0 | $0 |
| Hernan Vaisman | Group President, Flavors | 27 marca 2014 A | 22 485 | 0 | 0 | $0 |
| Gail S Belmuth | President Corp. Comm. | 25 stycznia 2005 A | 2 616 | 0 | 0 | $0 |
| Angelica T. Cantlon | EVP, Chief Human Resources | 2 maja 2016 A | 37 542 | 0 | 0 | $0 |
| Ahmet Baydar | EVP, Research & Development | 31 marca 2016 M | 24 869 | 0 | 0 | $0 |
| Douglas D. Tough | Chairman of the Board | 1 grudnia 2014 M | 218 050 | 0 | 0 | $0 |
| Beth Ford | EVP, Supply Chain | 22 grudnia 2011 A | 38 573 | 0 | 0 | $0 |
| Dennis M Meany | SVP, Gen. Counsel & Sec'y | 22 grudnia 2010 A | 64 700 | 0 | 0 | $0 |
| Kimberly A. Hendricks | Controller | 30 czerwca 2009 J | 2 208 | 0 | 0 | $0 |
| Steven J Heaslip | Senior VP Human Resources | 30 czerwca 2009 A | 51 148 | 0 | 0 | $0 |
| Joseph Faranda | Chief Marketing Officer | 16 lutego 2009 F | 15 044 | 0 | 0 | $0 |
| James H Dunsdon | Chief Transition Officer | 20 grudnia 2007 A | 43 904 | 0 | 0 | $0 |
| James P Huether | Corporate Controller | 11 maja 2007 M | 15 702 | 0 | 0 | $0 |
| Clint D Brooks | Senior VP, R & D | 11 stycznia 2007 M | 47 527 | 0 | 0 | $0 |
| Arun Bewoor | VP, Regional Manager | 15 grudnia 2006 M | 3 000 | 0 | 0 | $0 |
| Charles D Weller | VP and Treasurer | 14 grudnia 2006 M | 7 944 | 0 | 0 | $0 |
| Christopher Gibson | VP Global Accounts | 11 grudnia 2006 M | 5 704 | 0 | 0 | $0 |
| Robert Burns | Sr.VP, Regional Manager | 15 listopada 2006 M | 390 | 0 | 0 | $0 |
| Dennis Wall | Regional Manager | 10 listopada 2006 M | 369 | 0 | 0 | $0 |
| Rob J M Edelman | VP and Regional Manager | 7 listopada 2006 S | 3 410 | 0 | 0 | $0 |
| Wayne D Howard | EVP Global Operations | 24 stycznia 2006 A | 3 508 | 0 | 0 | $0 |
| Graciela M Ferro | VP Global Accounts | 17 marca 2005 M | 3 187 | 0 | 0 | $0 |
| Neil Humphreys | Vice President | 17 lutego 2004 M | 2 832 | 0 | 0 | $0 |
| Stephen A Block | Senior Vice President | 23 grudnia 2003 A | 7 694 | 0 | 0 | $0 |
| Michael J Cook | Dyrektor | 1 maja 2015 M | 1 755 | 0 | 0 | $0 |
| Arthur C Martinez | Dyrektor | 1 maja 2015 M | 2 405 | 0 | 0 | $0 |
| Margaret Hayes Adame | Dyrektor | 1 maja 2012 M | 21 688 | 0 | 0 | $0 |
| Peter A Georgescu | Dyrektor | 3 maja 2011 M | 40 825 | 0 | 0 | $0 |
| Burton M Tansky | Dyrektor | 27 kwietnia 2010 M | 8 143 | 0 | 0 | $0 |
| Gunter Blobel MD PHD | Dyrektor | 28 kwietnia 2009 M | 13 855 | 0 | 0 | $0 |
| William D Van Dyke III | Dyrektor | 30 września 2003 A | — | 0 | 0 | $0 |
| Winder Investment Pte Ltd | Posiadacz 10% | 21 lutego 2019 P | 20 300 000 | 0 | 0 | $0 |
| Marc Birenkrant | — | 7 sierpnia 2026 S | 3 446 | 0 | 1 | $-85 000 |
| Michael Deveau | — | 6 sierpnia 2026 S | 5 199 | 0 | 1 | $-754 979 |
| Paul J Fribourg | — | 1 czerwca 2026 P | 2 682 730 | 8 | 4 | $31 275 738 |
| De Mendonca Ana Paula Teles | — | 4 maja 2026 M | 5 718 | 0 | 0 | $0 |
| Ralf Finzel | — | 4 maja 2026 M | 17 621 | 0 | 0 | $0 |
| Deborah Borg | — | 4 maja 2026 M | 37 925 | 0 | 0 | $0 |
| Yuvraj Arora | — | 1 maja 2026 M | 17 283 | 0 | 0 | $0 |
| Kevin O'Byrne | — | 1 maja 2026 M | 17 571 | 0 | 0 | $0 |
| Jesus B Mantas | — | 1 maja 2026 A | — | 0 | 0 | $0 |
| Dawn C Willoughby | — | 1 maja 2026 A | 434 | 0 | 0 | $0 |
| Virginia Drosos | — | 1 maja 2026 M | 2 434 | 0 | 0 | $0 |
| Mehmood Khan | — | 1 maja 2026 M | 7 173 | 0 | 0 | $0 |
| Brett Icahn | — | 1 maja 2026 M | 34 712 | 0 | 0 | $0 |
| Richard Mulligan | — | 1 maja 2026 M | 1 712 | 0 | 0 | $0 |
| Erik J Fyrwald | — | 1 maja 2026 M | 109 676 | 2 | 0 | $995 179 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 5 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Winder Investment Pte Ltd, Haldor Foundation, Freemont Capital Pte. Ltd. ×7 zgłoszenia | 4 lutego 2022 | — | Pierwotne zgłoszenie | — | SEC |
| Henry P. van Ameringen ×3 zgłoszenia | 18 maja 2006 | — | Pierwotne zgłoszenie | — | SEC |
| George Rowe, Jr. ×2 zgłoszenia | 26 maja 2004 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 18 grudnia 2002 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 18 grudnia 2002 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 155 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| RSPM · Invesco Exchange-Traded Fund Trust | 4,25% | 91 561 SH | 8 sierpnia 2026 | Dziennie |
| ANEW · ProShares Trust | 2,32% | 2 356 NS | 31 maja 2026 | N-PORT |
| IYM · iShares Trust | 2,15% | 252 882 SH | 8 sierpnia 2026 | Dziennie |
| AMID · EA Series Trust | 1,87% | 25 751 NS | 29 maja 2026 | N-PORT |
| UYM · ProShares Trust | 1,73% | 9 090 NS | 31 maja 2026 | N-PORT |
| FXZ · First Trust Exchange-Traded AlphaDE… | 1,54% | 84 008 NS | 30 kwietnia 2026 | N-PORT |
| VAW · VANGUARD WORLD FUND | 1,29% | 729 993 SH | 8 sierpnia 2026 | Dziennie |
| FMAT · FIDELITY COVINGTON TRUST | 1,15% | 98 987 NS | 30 kwietnia 2026 | N-PORT |
| SZNE · Pacer Funds Trust | 1,04% | 1 987 NS | 30 kwietnia 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 1,00% | 4 494 NS | 31 maja 2026 | N-PORT |
| FEGE · RBB Fund Trust | 0,84% | 214 489 NS | 31 maja 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 0,80% | 5 155 NS | 30 kwietnia 2026 | N-PORT |
| MXI · iShares Trust | 0,69% | 28 781 SH | 8 sierpnia 2026 | Dziennie |
| ABCS · EA Series Trust | 0,65% | 974 NS | 29 maja 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,64% | 127 828 SH | 8 sierpnia 2026 | Dziennie |
| RCGE · EA Series Trust | 0,48% | 6 360 NS | 30 kwietnia 2026 | N-PORT |
| SMIZ · Zacks Trust | 0,42% | 14 093 NS | 31 maja 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 21 301 NS | 30 kwietnia 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,33% | 97 465 NS | 30 kwietnia 2026 | N-PORT |
| IMCV · iShares Trust | 0,30% | 40 850 SH | 8 sierpnia 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,25% | 24 806 SH | 8 sierpnia 2026 | Dziennie |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,24% | 554 109 SH | 8 sierpnia 2026 | Dziennie |
| RSP · Invesco Exchange-Traded Fund Trust | 0,22% | 2 498 017 SH | 8 sierpnia 2026 | Dziennie |
| SIZE · iShares Trust | 0,22% | 11 232 SH | 8 sierpnia 2026 | Dziennie |
| EUSA · iShares, Inc. | 0,21% | 47 327 SH | 8 sierpnia 2026 | Dziennie |
| IWS · iShares Trust | 0,21% | 386 345 SH | 8 sierpnia 2026 | Dziennie |
| DFVE · DoubleLine ETF Trust | 0,21% | 779 NS | 31 marca 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,20% | 1 765 745 SH | 8 sierpnia 2026 | Dziennie |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,19% | 10 256 NS | 31 maja 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,18% | 42 327 NS | 31 maja 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,17% | 778 992 SH | 8 sierpnia 2026 | Dziennie |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,16% | 205 000 | 8 sierpnia 2026 | Dziennie |
| IWR · iShares Trust | 0,15% | 1 041 200 SH | 8 sierpnia 2026 | Dziennie |
| IMCB · iShares Trust | 0,15% | 29 348 SH | 8 sierpnia 2026 | Dziennie |
| FEUS · FlexShares Trust | 0,14% | 2 166 NS | 30 kwietnia 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,13% | 13 703 SH | 8 sierpnia 2026 | Dziennie |
| XOEF · iShares Trust | 0,12% | 325 SH | 8 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,11% | 2 781 420 SH | 8 sierpnia 2026 | Dziennie |
| LRND · New York Life Investments ETF Trust | 0,11% | 4 311 NS | 30 kwietnia 2026 | N-PORT |
| VLUE · iShares Trust | 0,10% | 106 590 SH | 8 sierpnia 2026 | Dziennie |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 5 920 NS | 30 kwietnia 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,09% | 2 628 397 SH | 8 sierpnia 2026 | Dziennie |
| EQL · ALPS ETF Trust | 0,09% | 15 730 NS | 31 maja 2026 | N-PORT |
| USXF · iShares Trust | 0,08% | 14 526 SH | 8 sierpnia 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,08% | 95 978 SH | 8 sierpnia 2026 | Dziennie |
| VYM · VANGUARD WHITEHALL FUNDS | 0,08% | 1 017 872 SH | 8 sierpnia 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 8 339 SH | 8 sierpnia 2026 | Dziennie |
| ESG · FlexShares Trust | 0,07% | 1 333 NS | 30 kwietnia 2026 | N-PORT |
| IVE · iShares Trust | 0,07% | 423 829 SH | 8 sierpnia 2026 | Dziennie |
| JFLI · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 457 NS | 30 kwietnia 2026 | N-PORT |